Nektar TherapeuticsNKTR
Close of Friday, October 23, 2026 · Nektar Therapeutics is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$37.22
vs its Pivot
-42.8%
OnlyAlpha Score
35
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -37.3% | -12.0% | -39.8% | +65.2% | -32.2% |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| OrbiMed Carl Gordon | 0.6% of holdings |
Members of Congress who traded it
| Josh Gottheimer D · NJ | 1 buys · 1 sells · last sell 2018-06-21 |
Healthcare · Biotech
Get NKTR in your free daily emailAfter every close: whether NKTR is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track NKTR free → Full Stock check
Track NKTR free → Full Stock check